FindTrial
Sign In

Can adding growth factor from platelets to epidermal cell suspension improve repigmentation in stable vitiligo.A double blinded randomised control study

Can suspending non cultured epidermal cell suspension (NCES) in platelet rich plasma(PRP) improve surgical repigmentation in stable vitiligo. A double blinded randomized control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008550
Enrollment
20
Registered
2017-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vitiligo

Interventions

Intervention1: NCES suspended in PRP, non cultured epidermal cells suspended in phosphate buffered saline.: Non cultured epidermal cells suspended in Platelet rich plasma,non cultured epidermal cells

Sponsors

AIIMS dermatology department
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with segmental or generalized vitiligo stable for at least 1 year.

Exclusion criteria

Exclusion criteria: Pregnancy Patients with actively spreading vitiligo,appearance of new lesion, koebnerization Keloid/bleeding diathesis Active infection at the site Other auto immune diseases Inability to come for follow up for at least 6 months

Design outcomes

Primary

MeasureTime frame
More than 75% repigmentation after 6 monthsTimepoint: 6 months—

Secondary

MeasureTime frame
To compare the healing time on both recipient and donor sites after addition of PRPTimepoint: 6 months—

Countries

India

Contacts

Public ContactDrNimitha

A.I.I.M.S

aiimsvks@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026